`Case 1:20-cv-01644-RGA Document 1-43 Filed 12/03/20 Page 1 of 4 PageID #: 1255
`
`
`
`
`
`EXHIBIT 43
`
`
`
`
`
`EXHIBIT 43
`
`
`
`
`
`
`
`
`11/6/2020
`
`VeriSeq NIPT Solution v2 FAQs
`Case 1:20-cv-01644-RGA Document 1-43 Filed 12/03/20 Page 2 of 4 PageID #: 1256
`
`VeriSeq NIPT Solution v2
`Frequently Asked Questions
`
`Support Center / Support Resources:
`
`GENERAL
`
`(cid:0)
`
`What types of samples does the solution use?
`
`The solution uses maternal peripheral whole blood specimens collected in Streck BCT tubes from pregnant women of at least
`10 weeks gestation.
`
`(cid:0)
`
`What equipment do I need to run the VeriSeq NIPT Solution v2?
`
`The solution is performed on three primary pieces of equipment:
`
`A VeriSeq NIPT MicroLab STAR from Hamilton.
`A next-generation sequencing instrument, such as a NextSeq 550Dx.
`A VeriSeq Onsite Server v2 or an existing VeriSeq Onsite Server upgraded to version 2.
`Additional lab equipment is necessary to complete a run. Refer to the VeriSeq NIPT Solution v2 Consumables and Equipment
`list (document # 1000000076886) for a full list of required equipment.
`
`(cid:0)
`
`Does the genomewide screen cover the entire genome?
`
`No. For genomewide screens, certain regions are excluded from analysis. A list of such blacklisted regions is available on the
`Illumina Support product page under Product Files. Genomic anomaly detection is only performed on non-excluded regions.
`
`(cid:0)
`
`Can the solution be performed on women who conceived via assisted reproductive
`technology (ART), including use of a donor egg?
`
`Yes, the solution uses a non-single nucleotide polymorphism (SNP) technology that does not rely on the similarities and
`differences between maternal and fetal cfDNA.
`
`(cid:0)
`
`Can the solution detect polyploidies, such as triploidy?
`
`The solution is not intended to detect polyploidies.
`
`(cid:0)
`
`What is the difference between basic and genomewide screens in the VeriSeq NIPT Solution
`
`https://support.illumina.com/clinical_support/clinical_kits/veriseq-nipt-solution-v2/faqs.html
`
`1/3
`
`
`
`11/6/2020
`
`VeriSeq NIPT Solution v2 FAQs
`Case 1:20-cv-01644-RGA Document 1-43 Filed 12/03/20 Page 3 of 4 PageID #: 1257
`
`v2?
`
`The basic screen provides information on the trisomy status for chromosomes 21, 18, 13, X, and Y only. Genomewide screens
`provide partial deletions and duplications of 7 MB or more for all autosomes and aneuploidy status for all chromosomes.
`
`In some countries, depending on regulations, fetal sex reporting and sex chromosome aneuploidy (SCA) reporting is not
`available.
`
`LIBRARY PREP
`
`(cid:0)
`
`Can the workflow be prepared manually?
`
`No. The entire workflow is automated.
`
`(cid:0)
`
`How many samples can I run?
`
`You can conduct runs in 24, 48, or 96 sample batches.
`
`(cid:0)
`
`Are index adapters included in the Sample Prep kit?
`
`Yes. The Sample Prep kit includes a DNA Adapter Plate.
`
`(cid:0)
`
`How many sample sequencing libraries can be multiplexed together in one pool?
`
`You can use 24 or 48 sample pools.
`
`(cid:0)
`
`Does the solution require pre- and post-PCR lab spaces?
`
`There is no PCR step in the workflow. Therefore, no post-PCR lab space is required.
`
`SOFTWARE
`
`(cid:0)
`
`Can I run a sample with the basic screen analysis option and then later reanalyze the same
`sample with the genomewide analysis?
`
`No. The sample needs to be reprocessed from the start for another analysis option.
`
`(cid:0)
`
`Can samples on the same run have different screen types?
`
`Yes.
`
`(cid:0)
`
`https://support.illumina.com/clinical_support/clinical_kits/veriseq-nipt-solution-v2/faqs.html
`
`2/3
`
`
`
`11/6/2020
`
`(cid:0)
`
`VeriSeq NIPT Solution v2 FAQs
`Case 1:20-cv-01644-RGA Document 1-43 Filed 12/03/20 Page 4 of 4 PageID #: 1258
`What software does the solution require?
`
`All software is provided with installation.
`
`(cid:0)
`
`Can I download the VeriSeq NIPT Assay Software v2?
`
`No. You must either purchase the VeriSeq Onsite Server v2 with the VeriSeq NIPT Assay Software v2 pre-installed or upgrade
`an existing VeriSeq Onsite Server to v2.
`
`(cid:0)
`
`What chromosomes are reported by the VeriSeq NIPT Assay Software v2?
`
`The basic screen provides information on the trisomy status for chromosomes 21, 18, 13, X, and Y only. Genomewide screens
`provide partial deletions and duplications of 7 MB or more for all autosomes and aneuploidy status for all chromosomes.
`
`In some countries, depending on regulations, fetal sex reporting and sex chromosome aneuploidy reporting (SCA) is not
`available.
`
`(cid:0)
`
`Can I incorporate results with my LIMS system?
`
`Yes, all files are in MD5 format, which makes it easy to incorporate into any LIMS system. However, LIMS software should not
`be installed directly onto the PC for the VeriSeq NIPT MicroLab STAR.
`
`(cid:0)
`
`Does the solution fail samples based on a fetal fraction cutoff?
`
`No.
`
`Contact Us
`
`Other Support
`
`Innovative technologies
`
`At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making
`studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative,
`flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on
`collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this
`challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life
`science research, translational and consumer genomics, and molecular diagnostics.
`For Research Use Only. Not for use in diagnostic procedures (except as specifically noted).
`
`© 2020 Illumina, Inc. All rights reserved.
`
`All trademarks are the property of Illumina, Inc. or their respective owners.
`For specific trademark information, see www.illumina.com/company/legal.html.
`
`Privacy Policy
`
`(cid:0)
`
`(cid:0)
`
`
`
`
`
`
`
`
`
`https://support.illumina.com/clinical_support/clinical_kits/veriseq-nipt-solution-v2/faqs.html
`
`3/3
`
`